Encompass Health Declares Quarterly Cash Dividend on Common Stock, Payable on April 15, 2026
Encompass Health Corporation announced that its board of directors has declared a quarterly cash dividend of $0.19 per share on its common stock. This dividend is payable on April 15, 2026, to shareholders of record as of April 1, 2026. This announcement highlights the company's consistent return of capital to its investors.
Encompass Health Declares Quarterly Cash Dividend
Encompass Health's board has declared a quarterly cash dividend of $0.19 per share, payable on April 15, 2026, to shareholders of record as of April 1, 2026. The company is recognized as a leader in inpatient rehabilitation, operating 173 hospitals, and emphasizes that future dividend amounts are subject to change based on board authority and market adaptability. Analyst ratings are generally positive, with Barclays maintaining an "Overweight" rating and increasing price targets.
Encompass Health declares dividend on common stock
Encompass Health Corp. (NYSE: EHC) announced its board of directors has declared a quarterly cash dividend of $0.19 per share on its common stock. The dividend will be payable on April 15, 2026, to shareholders of record as of April 1, 2026. Encompass Health is a leading owner and operator of inpatient rehabilitation hospitals in the United States.
Encompass Health declares dividend on common stock
Encompass Health Corp. (NYSE: EHC) announced its board of directors declared a quarterly cash dividend of $0.19 per share on its common stock. The dividend is payable on April 15, 2026, to shareholders of record as of April 1, 2026. Encompass Health is a leading owner and operator of inpatient rehabilitation hospitals in the United States.
Encompass Health (EHC): Buy, Sell, or Hold Post Q4 Earnings?
Encompass Health (EHC) shares have declined by 10.7% over the last six months, prompting investors to question its future. The company's long-term revenue growth has been mediocre at 5% CAGR over five years, and its same-store sales growth of 4.9% year-on-year has lagged behind peers. Despite a reasonable 18.5x forward P/E valuation, the article suggests there are more attractive investment opportunities elsewhere.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi
Encompass Health Corp. (NYSE: EHC) has announced plans for a new 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. This facility will provide specialized care for patients recovering from various debilitating conditions, offering 24-hour nursing, physical, occupational, and speech therapies. This will be Encompass Health's second location in Mississippi, aimed at expanding high-quality rehabilitation services in the Jackson area.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi
Encompass Health Corp. announced plans to build a new 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. This facility will provide specialized care for patients recovering from debilitating illnesses and injuries, including physical, occupational, and speech therapies. This will be Encompass Health's second location in Mississippi, aimed at expanding high-quality rehabilitation services in the Jackson area and central Mississippi.
Encompass Health to build rehab hospital in Flowood
Encompass Health Corp. announced plans to construct a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. This facility will provide specialized rehabilitation services for patients recovering from various debilitating illnesses and injuries, including strokes, spinal cord injuries, and complex orthopedic conditions. The hospital, featuring private rooms and advanced therapy technologies, aims to expand high-quality rehabilitation access for residents in the Jackson area and throughout central Mississippi.
Major new MS development is coming to Flowood. What is it? When will it open?
Encompass Health plans to open a new 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, by 2027. This facility will offer specialized care for patients recovering from conditions like strokes and major injuries, including 24-hour nursing and various therapies. It marks Encompass Health's second location in Mississippi, expanding access to high-quality rehabilitation services in the Jackson area.
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi
Encompass Health plans to construct a new 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. This facility will be their second in Mississippi, providing specialized care for patients recovering from various debilitating conditions, including strokes and spinal cord injuries. The hospital aims to offer comprehensive rehabilitation services with advanced technology, serving the Jackson area and central Mississippi.
New 50-bed rehab hospital to bring stroke care closer to central Mississippi
Encompass Health (NYSE: EHC) announced plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. This facility will be the company's second in Mississippi and aims to expand access to specialized post-acute rehabilitation services for the Jackson area and central Mississippi, treating patients recovering from conditions such as strokes, neurological disorders, and complex orthopedic issues. The hospital will feature 24-hour nursing, various therapies, advanced technologies, and an in-house dialysis suite.
Insider Sell: Mark Tarr Sells 150,000 Shares of Encompass Health Corp (EHC)
Mark Tarr, President & CEO of Encompass Health Corp (EHC), sold 150,000 shares of the company on February 11, 2026, reducing his total holdings to 377,070 shares. This transaction is part of a pattern over the past year with eight insider sells and no buys. Despite the insider selling, EHC's stock is currently considered fairly valued with a price-to-GF-Value ratio of 1.07.
Enhabit, Encompass gain $43.1M and 43% of VitalCaring
Enhabit, Inc. and Encompass Health Corporation have collected $43.1 million in full satisfaction of claims against former officers for "egregious breaches of the duty of loyalty." Additionally, the companies will split 43% of VitalCaring Group’s ongoing profits and exit proceeds through a constructive trust. This settlement stems from a December 2024 judgment in the Delaware Court of Chancery.
5 Must-Read Analyst Questions From Encompass Health's Q4 Earnings Call
Encompass Health reported strong Q4 results, with revenue of $1.54 billion and adjusted EPS of $1.46, driven by efficient labor cost management and growth in patient discharges. Analysts queried management on topics including the impact of new hospital ramp-ups, improved labor costs, affirmation rates under RCD, the financial impact of the TEAM payment model, and the benefits of their partnership with Palantir. The company anticipates continued operational improvements and faces catalysts like capacity additions and regulatory transitions in upcoming quarters.
Encompass Health Corporation (NYSE:EHC) Q4 2025 Earnings Call Transcript
Encompass Health (NYSE: EHC) reported strong Q4 and full-year 2025 results, with revenue increasing 10.5% and EBITDA growing 14.9%. The company discussed its strategic investments in capacity expansion, including new small-format hospitals, and its proactive approach to navigating regulatory changes like RCD and the TEAM model. Management also addressed challenges with Medicare Advantage conversion rates, emphasizing efforts to advocate for patient access to care and leverage data for competitive advantage.
Truist Securities reiterates Buy rating on Encompass Health stock after solid Q4 By Investing.com
Truist Securities has reiterated its Buy rating and $140.00 price target for Encompass Health Corp (NYSE:EHC) after the company's strong fourth-quarter results, which included solid volume, cash flow, and better-than-expected margins. The price target suggests a 31% upside from the current price. Encompass Health's financial strength is supported by robust profitability, favorable labor trends, and a long history of dividend payments, with the company also significantly surpassing analyst expectations for Q4 earnings per share and adjusted EBITDA.
Truist Securities reiterates Buy rating on Encompass Health stock after solid Q4 By Investing.com
Truist Securities has reiterated its Buy rating and $140.00 price target on Encompass Health Corp (NYSE:EHC) after the company reported strong fourth-quarter results, exceeding expectations and providing optimistic 2026 guidance. The firm highlighted Encompass Health's solid volume, cash flow, differentiated scale, and robust financial health, supported by InvestingPro data and sustained dividend payments. This positive outlook is further bolstered by recent earnings beats and a "Strong Buy" rating from Raymond James.
Truist Securities reiterates Buy rating on Encompass Health stock after solid Q4
Truist Securities reiterated its Buy rating and $140.00 price target for Encompass Health Corp (NYSE:EHC) after the company reported strong Q4 results, with solid volume, cash flow, and margins exceeding expectations. The firm highlighted Encompass Health's differentiated scale, capabilities, and robust cash flow, leading to increased estimates while maintaining a positive outlook. This follows EHC's significant outperformance in Q4 2025 earnings and ongoing analyst support.
A Look At The Intrinsic Value Of Encompass Health Corporation (NYSE:EHC)
This article analyzes the intrinsic value of Encompass Health Corporation (NYSE: EHC) using a two-stage Discounted Cash Flow (DCF) model. The analysis suggests that EHC's current share price of US$105 is close to its estimated fair value of US$120, implying it is trading at a slight discount. The company also has an analyst price target of US$142, which is 18% above the fair value estimate.
Why Is Encompass Health (EHC) Stock Rocketing Higher Today
Encompass Health (EHC) stock surged 11.9% after reporting strong fourth-quarter earnings that beat consensus estimates and raising its profit forecast for the full year 2026. The company's optimistic outlook for adjusted earnings per share, exceeding analyst projections, and improved operating and free cash flow margins boosted investor confidence. Despite this jump, the stock is still trading 12.5% below its 52-week high from October 2025.
Earnings call transcript: Encompass Health Q4 2025 beats EPS forecast, stock surges
Encompass Health (EHC) significantly surpassed Q4 2025 EPS forecasts, reporting $1.46 against an anticipated $1.30, leading to a 17.44% stock surge premarket. The company's revenue met projections at $1.54 billion, with full-year 2025 revenue growing 10.5% and EBITDA increasing by 14.9%. Encompass Health provided strong 2026 guidance, projecting net operating revenue between $6.365 billion and $6.465 billion, and detailed strategic expansions, disciplined cost management, and adaptation to regulatory changes.
Encompass Health (NYSE:EHC) Reports Q4 CY2025 In Line With Expectations, Stock Jumps 17.5%
Encompass Health (NYSE:EHC) reported Q4 CY2025 results that met revenue expectations and beat adjusted EPS estimates, leading to a 17.5% stock jump. The company's revenue increased by 9.9% year-on-year to $1.54 billion, and its non-GAAP profit per share of $1.46 exceeded analyst consensus by 12.1%. Encompass Health also provided an adjusted EPS guidance for FY2026 that beat analyst estimates.
Baron Health Care Fund Remains Positive on Encompass Health Corporation’s (EHC) Growth Prospects
The Baron Health Care Fund maintains a positive outlook on Encompass Health Corporation (EHC), a leader in inpatient rehabilitation services, despite a slight dip in share performance. The fund believes the recent decline in same-store discharges was an anomaly and that strong fundamentals, demographic tailwinds, and expanded hospital joint venture opportunities will drive future growth. Encompass Health's management has also raised its new-bed growth outlook, expressing confidence in achieving total volume growth.
Encompass Health: Fourth Quarter Earnings Overview
Encompass Health Corp. announced strong fourth-quarter earnings, reporting a net profit of $146.1 million and adjusted earnings of $1.46 per share, surpassing analyst expectations of $1.29 per share. The company generated $1.54 billion in revenue and provided full-year earnings guidance between $5.81 and $6.10 per share, with revenue projected to be between $6.37 billion and $6.47 billion.
Encompass Health Corp (NYSE:EHC) Stock Soars on Strong Q4 2025 Earnings Beat
Encompass Health Corp (NYSE:EHC) reported strong financial results for Q4 2025, with non-GAAP earnings per share of $1.46 significantly beating analyst expectations of $1.31, leading to a substantial 17.5% surge in its stock during after-hours trading. Despite revenue slightly missing estimates, the market reacted positively to the robust profitability and the company's optimistic revenue guidance of approximately $6.42 billion for the full year 2026. This performance signals strong operational momentum and confidence in its future trajectory as the largest operator of inpatient rehabilitation hospitals.
Encompass Health Q4 Earnings Exceed Expectations
Encompass Health reported a strong Q4 performance, with non-GAAP EPS of $1.46 and revenues of $1.55 billion, both exceeding analyst expectations. This robust financial health and significant year-over-year revenue growth of 6.9% are expected to drive a positive market reaction, increasing investor confidence and potentially boosting the company's stock price. With ongoing operational optimizations and service expansions, the company anticipates maintaining its growth momentum and strengthening its position in the healthcare sector.
Encompass Health Q4 Earnings Report: What Investors Need to Know
Encompass Health (NYSE: EHC) released its Q4 earnings report on February 5, 2026, beating estimated earnings per share (EPS) by 12.31% with an EPS of $1.46 against an estimate of $1.3. The company also reported a revenue increase of $140.00 million compared to the same period last year. Despite beating EPS last quarter, the share price dropped 7.02% the following day.
Encompass Health stock rating reiterated by KeyBanc amid recent weakness
KeyBanc has reiterated an Overweight rating and a $140.00 price target for Encompass Health Corp (NYSE:EHC), despite a 25% stock decline since its third-quarter report. The decline is attributed to concerns over fourth-quarter same-store volumes and uncertainty surrounding the TEAM value-based care model, but KeyBanc views the pullback as an attractive entry point for the "durable, high-quality secular grower." InvestingPro data supports an undervalued assessment, with analysts maintaining a Strong Buy consensus, while recent company developments include a positive outlook revision from Moody’s Ratings and plans for new inpatient rehabilitation hospitals.
Encompass Health announces date of 2025 fourth quarter earnings call
Encompass Health Corp. (NYSE: EHC) has announced that it will report its fourth-quarter 2025 financial results after market close on Thursday, February 5, 2026. The company will host an investor conference call on Friday, February 6, 2026, at 10 a.m. ET to discuss these results. Details for accessing the call via phone or live webcast are provided.
Earnings To Watch: Encompass Health (EHC) Reports Q4 Results Tomorrow
Encompass Health (EHC) is scheduled to report its Q4 results this Thursday after market hours. Analysts anticipate a 9.6% year-on-year revenue growth to $1.54 billion and adjusted earnings of $1.30 per share. Investors are watching closely, especially given the stock's recent 12.4% dip compared to the healthcare sector's average 1.7% decline.
Encompass Health Corporation (NYSE:EHC) Receives Consensus Rating of "Buy" from Analysts
Encompass Health Corporation (NYSE:EHC) has received a consensus "Buy" rating from analysts, with an average 1-year price target of $142.86. Despite trading near its 52-week low of $92.53, institutional investors hold a significant 97.25% of the company's stock. The company, which provides post-acute healthcare services, has seen several analysts upgrade their ratings or increase price targets recently.
Encompass Health appoints Cain Hayes to board of directors By Investing.com
Encompass Health Corp. (NYSE:EHC) has appointed Cain A. Hayes, the former president and CEO of Point32Health, Inc., to its board of directors, adding significant healthcare payor expertise. This strategic move, announced shortly before the company's Q4 earnings release, is part of Encompass Health's board succession planning. The company, which operates 173 inpatient rehabilitation hospitals, maintains a "GREAT" financial health rating and has expanded operations with new facilities and received a positive outlook upgrade from Moody's Ratings.
Encompass Health Appoints New Board Member
Encompass Health has appointed Cain A. Hayes to its board of directors, leveraging his 20 years of experience in healthcare and financial services, including his previous role as CEO of Point32Health, to provide valuable payer insights. This strategic move aims to enhance the company's decision-making and maintain its leadership in inpatient rehabilitation services. Hayes is committed to contributing to the company's strategic direction and increasing long-term shareholder value.
Encompass Health appoints Cain Hayes to board of directors
Encompass Health Corp. has appointed Cain A. Hayes to its board of directors, leveraging his extensive healthcare payor expertise as the company prepares for its upcoming earnings release. Hayes, formerly CEO of Point32Health, brings over two decades of leadership experience in insurance and financial services. This appointment is part of the company's succession planning, further strengthening its governance as it continues strategic growth with new hospital constructions and positive outlook upgrades from Moody's Ratings and UBS.
Encompass Health appoints Cain Hayes to its board of directors
Encompass Health Corp. has appointed Cain A. Hayes to its board of directors. Hayes brings extensive experience in healthcare, strategic leadership, and risk management, having previously served as CEO of Point32Health, Inc., and Gateway Health Plan, Inc., following a career with Aetna and Nationwide. His appointment is expected to provide valuable payor perspective and contribute to the company's strategic direction and long-term stockholder value.
Encompass Health appoints Cain Hayes to its board of directors
Encompass Health Corp. (NYSE: EHC) has appointed Cain A. Hayes, the former president and CEO of Point32Health, Inc., to its board of directors. Hayes brings extensive experience in healthcare, strategic leadership, and risk management from his previous roles. His appointment aims to provide valuable payor perspective and expertise to the board as part of the company's ongoing succession planning.
Encompass Health Corporation $EHC Position Trimmed by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd significantly reduced its stake in Encompass Health Corporation (NYSE:EHC) by 68.0% in Q3, selling 14,889 shares and retaining 7,002 shares valued at $889,000. Despite this, analysts generally maintain a "Buy" rating for EHC, with an average target price of $142.86. The company maintains a strong institutional ownership of 97.25% and a market capitalization of $9.51 billion.
Thrivent Financial for Lutherans Raises Stock Holdings in Encompass Health Corporation $EHC
Thrivent Financial for Lutherans significantly increased its stake in Encompass Health Corporation (NYSE:EHC) by 57.8%, acquiring an additional 437,464 shares, bringing its total to 1,194,859 shares valued at approximately $151.5 million. This move highlights strong institutional interest, with 97.25% ownership by hedge funds and other institutional investors. Analysts maintain an average "Buy" rating for EHC, with a consensus price target of $142.86, substantially higher than its recent trading price of $94.48.
Lightrock Netherlands B.V. Raises Holdings in Encompass Health Corporation $EHC
Lightrock Netherlands B.V. increased its stake in Encompass Health Corporation by 12.4% during the third quarter, now owning 93,306 shares valued at $11.85 million. This makes Encompass Health the 15th largest holding for Lightrock, representing 2.6% of its portfolio. The company has a current "Buy" consensus rating from analysts with an average price target of $142.86, and recently exceeded Q3 EPS estimates with a 9.4% year-over-year revenue increase.
Short Interest in Encompass Health Corporation (NYSE:EHC) Increases By 19.7%
Short interest in Encompass Health Corporation (NYSE:EHC) grew by 19.7% in December, reaching 3,479,262 shares, which represents about 3.5% of the company's outstanding shares. This increase translates to a short-interest ratio of 3.5 days based on average daily trading volume. Despite the rise in short interest, analysts maintain a positive outlook with a consensus "Buy" rating and an average price target of $142.86.
Rehab Hospital to Open This May at Former Concordville Inn Site
Encompass Health is set to open its 50-bed Concordville rehabilitation hospital in Glen Mills this May, on the former site of the Concordville Inn. This is part of a $100 million investment by the company to open two new hospitals in the Philadelphia suburbs, with the second planned for Lower Providence in the fall. Lauren Grieder will serve as CEO of the Glen Mills facility, which will treat patients recovering from various serious conditions.
March 20th Options Now Available For Encompass Health (EHC)
New options contracts for Encompass Health (EHC) with a March 20th expiration date have started trading, offering investors interesting put and call opportunities. A $100.00 strike price put contract could yield a 2.35% return (13.41% annualized) if it expires worthless, while a $105.00 strike price covered call contract could offer a 4.13% total return if the stock is called away. These options present strategies for investors looking to either acquire EHC shares at a discount or generate additional income.
Q3 Rundown: Encompass Health (NYSE:EHC) Vs Other Outpatient & Specialty Care Stocks
This article provides a Q3 rundown of Encompass Health (NYSE:EHC) and other outpatient & specialty care stocks. It highlights the sector's mixed results, with Encompass Health experiencing a mixed quarter, Select Medical showing strength, and DaVita having the weakest performance. The industry faces growth opportunities from aging populations and technological advancements but also headwinds from reimbursement cuts and labor shortages.
Encompass Health announces date of 2025 fourth quarter earnings call
Encompass Health Corp. (NYSE: EHC) has announced that it will release its fourth-quarter 2025 financial results after the market closes on Thursday, February 5, 2026. The company will then host an investor conference call the following day, Friday, February 6, 2026, at 10 a.m. ET to discuss these results. Details for accessing the conference call via phone and webcast are provided for investors.
Encompass Health announces date of 2025 fourth quarter earnings call
Encompass Health Corp. (NYSE: EHC) announced it will release its fourth-quarter 2025 financial results after market close on Thursday, February 5, 2026. The company will host an investor conference call the following day, Friday, February 6, 2026, at 10 a.m. ET to discuss these results. Interested parties can access the call via phone or live webcast, with replay options available on their investor website.
Encompass Health announces date of 2025 fourth quarter earnings call
Encompass Health Corp. (EHC) announced it will report its fourth-quarter 2025 results on Thursday, February 5, 2026, after market close. The company will host an investor conference call on Friday, February 6, 2026, at 10 a.m. ET to discuss the results. Details for accessing the call and webcast are provided for investors.
Why Encompass Health’s next earnings update lands on Feb. 6
Encompass Health (NYSE: EHC) announced it will report its fourth-quarter 2025 results after market close on February 5, 2026. The company will host an investor conference call at 10:00 AM ET on February 6, 2026, to discuss these results. Investors can access the call via phone or a live webcast on their investor relations website.
Encompass Health announces date of 2025 fourth quarter earnings call
Encompass Health Corp. (NYSE: EHC) has announced that it will release its fourth-quarter 2025 financial results on Thursday, February 5, 2026, after market close. The company will then host an investor conference call the following day, February 6, 2026, at 10 a.m. ET to discuss these results. Details for accessing the call and webcast were provided.
Lobbying Update: $15,000 of ENCOMPASS HEALTH lobbying was just disclosed
Quiver LobbyingRadar reports that $15,000 of ENCOMPASS HEALTH (EHC) lobbying was disclosed for Q4 2025, focused on "General health care issues." The article also details recent EHC stock trading by members of Congress and company insiders, hedge fund activity, and current analyst ratings with price targets.
Encompass Health appoints Mark Miller as senior vice president of investor relations and strategic planning
Encompass Health has named Mark Miller as its senior vice president of investor relations and strategic planning, effective September 7, 2021. Miller brings 20 years of healthcare investment leadership experience and previously served as vice president of future market development at Maximus. He will take over from Crissy Carlisle, who has transitioned to chief financial officer for Encompass Health's home health and hospice business.
